V. Kecskemeti et I. Balogh, CARDIAC ULTRASTRUCTURAL EFFECTS OF THE PLATELET-ACTIVATING-FACTOR ANDITS ANTAGONIST BN-52021, Experimental and toxicologic pathology, 47(6), 1995, pp. 463-470
Platelet-activating factor-induced ultrastructural changes of myocardi
um were examined in isolated perfused guineapig heart. The platelet-ac
tivating factor (10(-9)-10(-7) M) caused the following electron micros
copic changes: a) dilated capillaries filled with platelets and aggreg
ated platelets. The endothelial cells adjoining the platelets remained
uninjured but pericapillary oedema was observed. b) in the myocardium
intracellular oedema, myofibrillar alterations, decrease of matrix de
nsity and rupture of crest in mitochondria can be seen. c) Ca2+ deposi
ts in the cytoplasm increased and appeared in mitochondria, too.d) the
intramitochondrially localised cytochromoxydase and succinic dehydrog
enase activities were decreased. e) using lanthanum tracer permeabilit
y alterations were observed. Pretreatment with BN 52021 (10(-6) M) com
pletely prevented the morphological effects of the platelet-activating
factor. From these results we conclude that the platelet-activating f
actor-induced vascular and ischemic like cellular damage appears to pl
ay an important role in the pathophysiology of myocardial ischemia.